BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24590774)

  • 1. Detection and clinical relevance of hematogenous tumor cell dissemination in patients with ductal carcinoma in situ.
    Banys M; Hahn M; Gruber I; Krawczyk N; Wallwiener M; Hartkopf A; Taran FA; Röhm C; Kurth R; Becker S; Solomayer EF; Wallwiener D; Staebler A; Fehm T
    Breast Cancer Res Treat; 2014 Apr; 144(3):531-8. PubMed ID: 24590774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breast.
    Banys M; Gruber I; Krawczyk N; Becker S; Kurth R; Wallwiener D; Jakubowska J; Hoffmann J; Rothmund R; Staebler A; Fehm T
    Breast Cancer Res Treat; 2012 Feb; 131(3):801-8. PubMed ID: 21455667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of disseminated tumor cells in bone marrow correlates with tumor stage and nodal involvement in cervical cancer patients.
    Fehm T; Banys M; Rack B; Jäger B; Hartkopf A; Taran FA; Janni W
    Int J Cancer; 2014 Feb; 134(4):925-31. PubMed ID: 23921989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ.
    Sänger N; Effenberger KE; Riethdorf S; Van Haasteren V; Gauwerky J; Wiegratz I; Strebhardt K; Kaufmann M; Pantel K
    Int J Cancer; 2011 Nov; 129(10):2522-6. PubMed ID: 21207426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis.
    Hartkopf AD; Taran FA; Wallwiener M; Hahn M; Becker S; Solomayer EF; Brucker SY; Fehm TN; Wallwiener D
    Eur J Cancer; 2014 Oct; 50(15):2550-9. PubMed ID: 25096167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow versus sentinel lymph node involvement in breast cancer: a comparison of early hematogenous and early lymphatic tumor spread.
    Hartkopf AD; Banys M; Krawczyk N; Staebler A; Becker S; Hoffmann J; Hahn M; Wallwiener M; Fehm T
    Breast Cancer Res Treat; 2012 Jan; 131(2):501-8. PubMed ID: 21971730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship Between Hematogenous Tumor Cell Dissemination and Cellular Immunity in DCIS Patients.
    Gruber IV; Hartkopf AD; Hahn M; Taran FA; Staebler A; Wallwiener D; Brucker SY; Hanke J; Fehm T
    Anticancer Res; 2016 May; 36(5):2345-51. PubMed ID: 27127142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of patients with ductal carcinoma in situ and sentinel node biopsy.
    Meretoja TJ; Heikkilä PS; Salmenkivi K; Leidenius MH
    Ann Surg Oncol; 2012 Jul; 19(7):2345-51. PubMed ID: 22395995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of Van Nuys Prognostic Index as a qualification criterion to sentinel lymph node biopsy in patients diagnosed with ductal carcinoma in situ.
    Nowikiewicz T; Wiśniewska M; Wiśniewski M; Zegarski W
    Pol Przegl Chir; 2015 Feb; 86(10):479-85. PubMed ID: 25720107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.
    Gröbe A; Blessmann M; Hanken H; Friedrich RE; Schön G; Wikner J; Effenberger KE; Kluwe L; Heiland M; Pantel K; Riethdorf S
    Clin Cancer Res; 2014 Jan; 20(2):425-33. PubMed ID: 24218516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ.
    Maffuz A; Barroso-Bravo S; Nájera I; Zarco G; Alvarado-Cabrero I; Rodríguez-Cuevas SA
    J Exp Clin Cancer Res; 2006 Jun; 25(2):223-7. PubMed ID: 16918134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of intraoperative frozen section examination of sentinel lymph nodes in ductal carcinoma in situ of the breast.
    Ballehaninna UK; Chamberlain RS
    Clin Breast Cancer; 2013 Oct; 13(5):350-8. PubMed ID: 23791128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
    Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
    Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
    Park HS; Park S; Cho J; Park JM; Kim SI; Park BW
    J Surg Oncol; 2013 Mar; 107(4):388-92. PubMed ID: 23007901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ.
    El-Tamer M; Chun J; Gill M; Bassi D; Lee S; Hibshoosh H; Mansukhani M
    Ann Surg Oncol; 2005 Mar; 12(3):254-9. PubMed ID: 15827818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
    Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD
    Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of disseminated tumor cells in locally advanced breast cancer patients before primary systemic therapy.
    Solá M; Margelí M; Castellá E; Cirauqui B; Mariscal A; Rull M; Julian JF; Luna M; Vallejo V; Fraile M
    Breast; 2013 Oct; 22(5):908-13. PubMed ID: 23683695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.